Uses and complications of isotretinoin therapy

被引:153
作者
Ellis, CN [1 ]
Krach, KJ [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Dermatol, A Alfred Taubman Ctr 1910, Ann Arbor, MI 48109 USA
关键词
D O I
10.1067/mjd.2001.113717
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Isotretinoin (13-cis-retinoic acid) is a retinoid that has been used over the past 2 decades to treat a wide variety of dermatologic conditions, some with great success. Although it is beneficial in many skill conditions, the side effects and toxicities of oral retinoids require careful monitoring by experienced physicians. The clinical applications of Oral retinoids continue to expand both within and beyond the field of dermatology.
引用
收藏
页码:S150 / S157
页数:8
相关论文
共 111 条
[61]   Solid persistent facial oedema (Morbihan's disease) following rosacea, successfully treated with isotretinoin and ketotifen [J].
Mazzatenta, C ;
Giorgino, G ;
Rubegni, P ;
de Aloe, G ;
Fimiani, M .
BRITISH JOURNAL OF DERMATOLOGY, 1997, 137 (06) :1020-1021
[62]  
*MED EC CO, 1999, 1999 PHYS DESK REF, P2651
[63]   A PREGNANCY-PREVENTION PROGRAM IN WOMEN OF CHILDBEARING AGE RECEIVING ISOTRETINOIN [J].
MITCHELL, AA ;
VANBENNEKOM, CM ;
LOUIK, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02) :101-106
[64]   Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma [J].
Moore, DF ;
Pazdur, R ;
Sugarman, S ;
Jones, D ;
Lippman, SM ;
Bready, B ;
Abbruzzese, JL .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06) :525-527
[65]   EFFECTS OF RETINOIDS ON HUMAN-LYMPHOCYTE FUNCTIONS INVITRO [J].
MORIGUCHI, S ;
JACKSON, JC ;
WATSON, RR .
HUMAN TOXICOLOGY, 1985, 4 (04) :365-378
[66]   INTERFERON ALFA-2A AND 13-CIS-RETINOIC ACID IN RENAL-CELL CARCINOMA - ANTITUMOR-ACTIVITY IN A PHASE-II TRIAL AND INTERACTIONS IN-VITRO [J].
MOTZER, RJ ;
SCHWARTZ, L ;
LAW, TM ;
MURPHY, BA ;
HOFFMAN, AD ;
ALBINO, AP ;
VLAMIS, V ;
NANUS, DM .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1950-1957
[67]   Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-alpha. A phase II study [J].
Nikolaou, AC ;
Fountzilas, G ;
Daniilidis, I .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1996, 110 (09) :857-861
[68]   Managing actinic keratoses with retinoids [J].
Odom, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (02) :S74-S78
[69]   ISOTRETINOIN TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED EOSINOPHILIC FOLLICULITIS - RESULTS OF AN OPEN, PILOT TRIAL [J].
OTLEY, CC ;
AVRAM, MR ;
JOHNSON, RA .
ARCHIVES OF DERMATOLOGY, 1995, 131 (09) :1047-1050
[70]   Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: Long-term follow-up [J].
Papadimitrakopoulou, VA ;
Hong, WK ;
Lee, JS ;
Martin, JW ;
Lee, JJ ;
Batsakis, JG ;
Lippman, SM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :257-258